Ischemia-modified albumin in stable coronary atherosclerotic heart disease: clinical diagnosis and risk stratification

摘要：

Background Ischemic modified albumin (IMA), a new serum biomarker of myocardial ischemia, has been introduced in the diagnosis of acute coronary syndrome (ACS).However, few studies have been carried out in patients with stable coronary atherosclerotic heart disease (CHD).We aimed to evaluate the value of IMA in the diagnosis of stable CHD and to demonstrate the correlation between IMA levels and the severity of myocardial ischemia.

作者: ZHONG Yi-gang

作者单位: Hangzhou First People”s Hospital

会议类型: 国内会议

会议名称: 第11届中国介入心脏病学大会

会议地点: 北京

会议语种:英文

页码: 32-32

在线出版日期: 2013-03-20（万方平台首次上网日期，不代表论文的发表时间）